Raising Health · 17 November 2022
At the source: Andreessen Horowitz, a16z Bio + Health ↗ · audio
Perhaps no area of healthcare has undergone such a rapid shift as telehealth during the Covid pandemic. But as the world emerges from the public health emergency, it's an open question what will happen with the regulatory aspects of telehealth. Daisy Wolf, deal partner at a16z Bio + Health, talked to Sarah Thomas, general counsel at Sameday Health, about asynchronous telehealth, working with regulators, how counsel thinks about inducements, and more.
As published with the episode at Raising Health ↗
No summary of this episode yet.